The Hunt for Perfect Cortisol Replacement

In this episode of My Adrenal Life, we explore the fourth and final article in our educational series, What Happens to Your Steroid Medication After You Swallow It?

Glucocorticoid replacement is essential for people living with adrenal insufficiency, but conventional oral hydrocortisone cannot fully reproduce the body’s natural cortisol rhythms. This raises an important question: Could changing when and how cortisol is delivered improve treatment outcomes?

We examine the science behind circadian and ultradian cortisol rhythms, why conventional hydrocortisone creates peaks and valleys in blood concentrations, and how researchers are developing alternative delivery methods.

A major focus is the difference between two modified-release hydrocortisone formulations: Plenadren, designed to provide daytime cortisol exposure, and Chronocort/Efmody, designed to more closely reproduce the natural rise in cortisol before waking.

We also discuss the January 2026 CHAMPAIN clinical trial, which compared these formulations in 58 patients with primary adrenal insufficiency. Chronocort produced substantially higher early-morning cortisol concentrations, and several patient-reported fatigue and quality-of-life measures favored Chronocort. However, not every outcome improved significantly, highlighting the need for further research.

The conversation also explores continuous subcutaneous hydrocortisone infusion, commonly called cortisol pump therapy. Clinical studies suggest pumps can more closely reproduce natural cortisol patterns, although research findings on improvements in symptoms and quality of life have been mixed.

We examine emerging technologies, including wearable cortisol sensors and the possibility of future systems that could combine continuous cortisol monitoring with automated medication delivery. These technologies are promising research directions but are not yet established routine treatment options.

Throughout the discussion, we consider why a more physiological cortisol curve does not automatically guarantee better health, why patient experiences vary, and why researchers must look beyond laboratory measurements to outcomes such as fatigue, sleep, adrenal crisis frequency, long-term health, and quality of life.

Although much of the existing research focuses on primary adrenal insufficiency, we also discuss the importance of expanding studies to include secondary, tertiary, and glucocorticoid-induced adrenal insufficiency.

The central takeaway: The future of glucocorticoid replacement may involve understanding not only how much cortisol a person receives, but when and how that cortisol becomes available—and whether those differences meaningfully improve everyday life.

To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.